Hinge Health CFO James Budge sells 47,720 shares

The four reported lots had weighted average sale prices ranging from $101.5272 to $104.3350 per share under a plan adopted June 11, 2026.

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) Chief Financial Officer James Budge sold 47,720 shares of Class A Common Stock on October 12, 2026, in four reported lots of 2,100, 21,702, 14,498 and 9,420 shares, at respective weighted average prices of $101.5272, $102.5381, $103.4800 and $104.3350 per share. Each sale was made under a Rule 10b5-1 trading plan adopted June 11, 2026.

Insider Trade Summary 10b5-1

Net Seller: 47,720 shares

Net Sell 4 txns

Insider Budge James

Role Chief Financial Officer

Sold 47,720 shs ($4.92M)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock F1, F2	2,100	$101.5272	$213K
Sale	Class A Common Stock F1, F3	21,702	$102.5381	$2.23M
Sale	Class A Common Stock F1, F4	14,498	$103.48	$1.50M
Sale	Class A Common Stock F1, F5	9,420	$104.335	$983K

Holdings After Transaction: Class A Common Stock — 296,728 shares (Direct)

Footnotes (5)

1. F1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
2. F2. Represents the weighted average sale price. The lowest price at which shares were sold was $101.00 and the highest price at which shares were sold was $101.93. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
3. F3. Represents the weighted average sale price. The lowest price at which shares were sold was $102.01 and the highest price at which shares were sold was $103.00. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
4. F4. Represents the weighted average sale price. The lowest price at which shares were sold was $103.01 and the highest price at which shares were sold was $103.99. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
5. F5. Represents the weighted average sale price. The lowest price at which shares were sold was $104.02 and the highest price at which shares were sold was $104.72. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

Key Figures

Shares sold: 47,720 shares Sale lot: 2,100 shares; weighted average $101.5272 per share Sale lot: 21,702 shares; weighted average $102.5381 per share +2 more

5 metrics

Shares sold 47,720 shares James Budge's reported sales on October 12, 2026

Sale lot 2,100 shares; weighted average $101.5272 per share October 12, 2026

Sale lot 21,702 shares; weighted average $102.5381 per share October 12, 2026

Sale lot 14,498 shares; weighted average $103.4800 per share October 12, 2026

Sale lot 9,420 shares; weighted average $104.3350 per share October 12, 2026

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, Class A Common Stock

3 terms

Rule 10b5-1 trading plan regulatory

"pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"Represents the weighted average sale price"

Class A Common Stock financial

"Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HNGE shares did James Budge sell?

James Budge sold 47,720 shares of Hinge Health Class A Common Stock on October 12, 2026. The sales were made under a Rule 10b5-1 trading plan adopted June 11, 2026.

What price ranges did James Budge's HNGE sales cover?

The reported ranges were $101.00–$101.93 for 2,100 shares, $102.01–$103.00 for 21,702 shares, $103.01–$103.99 for 14,498 shares, and $104.02–$104.72 for 9,420 shares. Each range corresponds to a reported sale lot on October 12, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/13/2026 - 05:28 PM EDT Accepted by SEC EDGAR 10/13/2026 - 05:28 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Budge James

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/12/2026		S(1)		2,100	D	$101.5272(2)	342,348	D
Class A Common Stock	10/12/2026		S(1)		21,702	D	$102.5381(3)	320,646	D
Class A Common Stock	10/12/2026		S(1)		14,498	D	$103.48(4)	306,148	D
Class A Common Stock	10/12/2026		S(1)		9,420	D	$104.335(5)	296,728	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.

2. Represents the weighted average sale price. The lowest price at which shares were sold was $101.00 and the highest price at which shares were sold was $101.93. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

3. Represents the weighted average sale price. The lowest price at which shares were sold was $102.01 and the highest price at which shares were sold was $103.00. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

4. Represents the weighted average sale price. The lowest price at which shares were sold was $103.01 and the highest price at which shares were sold was $103.99. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

5. Represents the weighted average sale price. The lowest price at which shares were sold was $104.02 and the highest price at which shares were sold was $104.72. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

	/s/ James Budge	10/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)